Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01821469
Other study ID # EssaiClinique_"BIP-ED"
Secondary ID 2011-A00425-36
Status Completed
Phase N/A
First received November 6, 2012
Last updated January 27, 2014
Start date May 2011
Est. completion date December 2013

Study information

Verified date January 2014
Source University Hospital, Grenoble
Contact n/a
Is FDA regulated No
Health authority France: Committee for the Protection of PersonnesFrance: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

This research project follows two main objectives: 1) Assess anatomical and functional cerebral abnormalities in bipolar disorder. 2) Evaluate anatomical and functional changes after the application of a psychoeducational program in these patients. Specifically, this project aims to assess neurophysiological (fMRI - activation and functional connectivity) and neuroanatomical (morphometry and diffusion tensor imaging) specificities related to bipolar disorders and the therapeutic response to the psychoeducation. The results of this thesis project would also contribute to the validation of a pathophysiological model of the bipolar disorder.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- clinical diagnosis of bipolar disorders

- euthymic (Montgomery and Asberg depression rating scale < 10, Young Mania rating scale < 10)

Exclusion Criteria:

- other concomitant psychiatric disorders

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
psychoeducation
Bipolar disorders are educated to learn about their pathology

Locations

Country Name City State
France Ums Irmage Grenoble

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary fMRI measurement (neurophysiological [fMRI - activation and functional connectivity]) measurements were performed before (T1) and after (T2) educational program of 12 sessions .One session last one hour and half once a week (they come at the hospital for all sessions : i.e. during 12 weeks). Thus, T1 to T2 is 3 months (average). measurements were performed at T1 and T2 (up to 3 months) Yes
See also
  Status Clinical Trial Phase
Recruiting NCT05537376 - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness N/A
Completed NCT00240721 - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder Phase 3
Completed NCT02242669 - Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders N/A
Completed NCT00888264 - A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder N/A
Completed NCT02807688 - Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses N/A
Completed NCT00253162 - A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol Phase 3
Not yet recruiting NCT02904083 - Study of the Effectiveness of Specific Training of Health Professionals on Adherence in Bipolar Disorder N/A
Completed NCT01729650 - Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) N/A
Recruiting NCT02843906 - Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection? N/A
Completed NCT01377896 - The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours N/A
Completed NCT00453804 - Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) Phase 4
Terminated NCT00047567 - Open-label Adjunctive Zonisamide for Bipolar Disorder Phase 4
Completed NCT03028545 - Representations and Strategies for Recovery N/A
Completed NCT00156325 - Escitalopram as a Mood Stabilizer for Bipolar II Disorder Phase 2
Completed NCT06034769 - Oral and Jaw Health in Bipolar Patients
Terminated NCT02936466 - Evaluation of a Serious Game for Patients With Bipolar Disorder Involved in a Psychoeducation Group N/A
Completed NCT00845988 - Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders Phase 4
Completed NCT00257075 - A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder Phase 3
Recruiting NCT01188395 - Bipolar Disorder With Alcoholism in Han Chinese N/A
Completed NCT01188148 - Series Studies of Bipolar Disorder-Valproate add-on Memantine Phase 2/Phase 3